Altamira Therapeutics Ltd. Other Receivables
Altamira Therapeutics Ltd. (CYTOF) had Other Receivables of $351.33 thousand as of 2024-12-31, per its 20-F filed 2025-04-30.
Financial Statements › Notes › Receivables
ifrs-full:OtherReceivables · last filed 2025-04-30
- 2023-12-31: Other Receivables 74.82K CHF.
- 2022-12-31: Other Receivables 755.99K CHF.
- 2021-12-31: Other Receivables 671.34K CHF.
CHF
| Period end | Other Receivables |
|---|---|
| 2023-12-31 | 74.82K CHF 20-F/A · filed 2024-04-22 |
| 2022-12-31 | 755.99K CHF 20-F/A · filed 2024-04-22 |
| 2021-12-31 | 671.34K CHF 20-F · filed 2023-05-16 |
USD
| Period end | Other Receivables |
|---|---|
| 2024-12-31 | $351.33K 20-F · filed 2025-04-30 |
| 2023-12-31 | $88.92K 20-F · filed 2025-04-30 |